Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLARITHROMYCIN vs CLEMASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLARITHROMYCIN vs CLEMASTINE: Safety Overview

Metric CLARITHROMYCIN CLEMASTINE
Total FAERS Reports 18,945 611
Deaths Reported 987 54
Death Rate 5.2% 8.8%
Hospitalizations 6,385 319
Average Patient Age 52.9 yrs 50.8 yrs
% Female Patients 67.0% 72.1%
FDA Approval Date Apr 25, 2019 Approved Prior to Jan 1, 1982
Manufacturer Asclemed USA, Inc. Genus Lifesciences
Route ORAL ORAL
Marketing Status Discontinued Discontinued